IL-33/ST2 signalling contributes to carrageenin-induced innate inflammation and inflammatory pain: Role of cytokines, endothelin-1 and prostaglandin E 2

British Journal of Pharmacology

Volumn 169, Issue 1, 2013, Pages 90-101

  Zarpelon, A C ^a   Cunha, T M ^b   Alves Filho, J C ^b,c   Pinto, L G ^b   Ferreira, S H ^b   McInnes, I B ^c   Xu, D ^c   Liew, F Y ^c   Cunha, F Q ^b   Verri, W A ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

carrageenin; cytokine; hyperalgesia; IL 33; innate inflammation; ST2

Indexed keywords

CARRAGEENAN; CHEMOKINE RECEPTOR ANTAGONIST; CLAZOSENTAN; CXCL1 CHEMOKINE; CYTOKINE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; FUCOIDIN; INDOMETACIN; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 33; MESSENGER RNA; MYELOPEROXIDASE; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVITY; GENE EXPRESSION; HYPERALGESIA; INFLAMMATION; INFLAMMATORY PAIN; INTRACELLULAR SIGNALING; LEUKOCYTE FUNCTION; MONOTHERAPY; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN TARGETING; TREATMENT RESPONSE;

ANIMALS; CARRAGEENAN; CYTOKINES; DINOPROSTONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; FEMALE; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKINS; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PAIN; RECEPTORS, INTERLEUKIN; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84876113308     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12110     Document Type: Article

References (59)

1. Alexander SP, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th edition. Br J Pharmacol 164 (Suppl. 1): S1-S324
2. Ali S, Huber M, Kollewe C, Bischiff SC, Falk W, Martin MU, (2007). IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci U S A 104: 18660-18665.
3. Alves-Filho JC, Sônego F, Souto FO, Freitas A, Verri WA Jr, Auxiliadora-Martins M, et al. (2010). Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat Med 16: 708-712.
4. Andrade MV, Iwaki S, Ropert C, Gazzinelli RT, Cunha-Melo J, Beaven MA, (2011). Amplification of cytokine production through synergistic activation of NFAT and AP-1 following stimulation of mast cells with antigen and IL-33. Eur J Immunol 41: 760-772.
5. Arshad MI, Rauch M, L'helgoualc'h A, Julia V, Leite-de-Moraes MC, Lucas-Clerc C, et al. (2011). NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis. Eur J Immunol 41: 2341-2348.
6. Baamonde A, Lastra A, Villazõn M, Bordallo J, Hidalgo A, Menéndez L, (2004). Involvement of endogenous endothelins in thermal and mechanical inflammatory hyperalgesia in mice. Naunyn Schmiedebergs Arch Pharmacol 369: 245-251.
7. Bourgeois E, Van LP, Samson M, Diem S, Barra A, Roga S, et al. (2009). The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-γ production. Eur J Immunol 39: 1046-1055.
8. Bradley WA, Gilliam EB, Gotto AM Jr, Gianturco SH, (1982). Apolipoprotein-E degradation in human very low density lipoproteins by plasma protease(s): chemical and biological consequences. Biochem Biophys Res Commun 109: 1360-1367.
9. Brint EK, Xu D, Liu H, Dunne A, McKenzie AN, O'Neill LA, et al. (2004). ST2 is an inhibitor of interleukin 1 receptor and toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol 5: 373-379.
10. Byrne SN, Beaugie C, O'Sullivan C, Leighton S, Halliday GM, (2011). The immune-modulating cytokine and endogenous alarmin interleukin-33 is upregulated in skin exposed to inflammatory UVB radiation. Am J Pathol 179: 211-222.
11. Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L, et al. (2007). IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A 104: 282-287.
12. Carvalho TT, Flauzino T, Otaguiri ES, Batistela AP, Zarpelon AC, Cunha TM, et al. (2011). Granulocyte-colony stimulating factor (G-CSF) induces mechanical hyperalgesia via spinal activation of MAP kinases and PI3K in mice. Pharmacol Biochem Behav 98: 188-195.
13. Casagrande R, Georgetti SR, Verri WA Jr, Dorta DJ, dos, Santos AC, Fonseca MJ, (2006). Protective effect of topical formulations containing quercetin against UVB-induced oxidative stress in hairless mice. J Photochem Photobiol B 84: 21-27.
14. Choi YS, Choi HJ, Min JK, Pyun BJ, Maeng YS, Park H, et al. (2009). Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production. Blood 114: 3117-3126.
15. Conte FP, Barja-Fidalgo C, Verri WA Jr, Cunha FQ, Rae GA, Penido C, et al. (2008). Endothelins modulate inflammatory reaction in zymosan-induced arthritis: participation of LTB4, TNF-alpha, and CXCL-1. J Leukoc Biol 84: 652-660.
16. Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH, (1992). The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 107: 660-664.
17. Cunha TM, Verri WA Jr, Vivancos GG, Moreira IF, Reis S, Parada CA, et al. (2004). An electronic pressure-meter nociception paw test for mice. Braz J Med Biol Res 37: 401-407.
18. Cunha TM, Verri WA Jr, Silva JS, Poole S, Cunha FQ, Ferreira SH, (2005). A cascade of cytokines mediates mechanical inflammatory hyperalgesia in mice. Proc Natl Acad Sci U S A 102: 1755-1760.
19. Cunha TM, Verri WA Jr, Schivo IR, Napimoga MH, Parada CA, Poole S, et al. (2008). Crucial role of neutrophils in the development of mechanical inflammatory hypernociception. J Leukoc Biol 83: 824-832.
20. Espinassous Q, Garcia-de-Paco E, Garcia-Verdugo I, Synguelakis M, von, Aulock S, Sallenave JM, et al. (2009). IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex. J Immunol 183: 1446-1455.
21. Faccioli LH, Souza GE, Cunha FQ, Poole S, Ferreira SH, (1990). Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration 'in vivo' by indirect mechanisms. Agents Actions 30: 344-349.
22. Fagundes CT, Amaral FA, Souza AL, Vieira AT, Xu D, Liew FY, et al. (2007). ST2, an IL-1R family member, attenuates inflammation and lethality after intestinal ischemia and reperfusion. J Leukoc Biol 81: 492-499.
23. Ferreira SH, Vargaftig BB, (1974). Inhibition by non-steroid anti-inflammatory agents of rabbit aorta contracting activity generated in blood by slow reacting substance C. Br J Pharmacol 50: 543-551.
24. Ferreira SH, Lorenzetti BB, Bristow AF, Poole S, (1988). Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 334: 698-700.
25. Hudson CA, Christophi GP, Gruber RC, Wilmore JR, Lawrence DA, Massa PT, (2008). Induction of IL-33 expression and activity in central nervous system glia. J Leukoc Biol 84: 631-643.
26. Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers-Walgreen B, Radstake TR, et al. (2006). IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci U S A 103: 3298-3303.
27. Jovanovic I, Radosavljevic G, Mitrovic M, Lisnic Juranic V, McKenzie AN, Arsenijevic N, et al. (2011). ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma. Eur J Immunol 41: 1902-1912.
28. Katz LB, Theobald HM, Bookstaff RC, Peterson RE, (1984). Characterization of the enhanced paw oedema response to carrageenan and dextran in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats. J Pharmacol Exp Ther 230: 670-677.
29. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). NC3Rs Reporting Guidelines Working Group. Br J Pharmacol 160: 1577-1579.
30. Kim HY, Chang YJ, Subramanian S, Lee HH, Albacker LA, Matangkasombut P, (2012). Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J Allergy Clin Immunol 129: 216-227.
31. Komai-Koma M, Xu D, Li Y, McKenzie AN, McInnes IB, Liew FY, (2007). IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol 37: 2779-2786.
32. Kouzaki H, Iijima K, Kobayashi T, O'Grady SM, Kita H, (2011). The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. J Immunol 186: 4375-4387.
33. Kurowska-Stolarska M, Stolarski B, Kewin P, Murphy G, Corrigan CJ, Ying S, et al. (2009). IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol 183: 6469-6477.
34. Lefrançais E, Roga S, Gautier V, Gonzalez-de-Peredo A, Monsarrat B, Girard JP, et al. (2012). IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc Natl Acad Sci U S A 109: 1673-1678.
35. McColl SR, Clark-Lewis I, (1999). Inhibition of murine neutrophil recruitment in vivo by CXC chemokine receptor antagonists. J Immunol 163: 2829-2835.
36. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
37. Moussion C, Ortega N, Girard JP, (2008). The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin. PLoS One 3: e3331.
38. Nelson MP, Christmann BS, Werner JL, Metz AE, Trevor JL, Lowell CA, et al. (2011). IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina. J Immunol 186: 2372-2381.
39. Oboki K, Ohno T, Kajiwara N, Arae K, Morita H, Ishii A, et al. (2010). IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci U S A 107: 18581-18586.
40. Pecaric-Petkovic T, Didichenko SA, Kaempfer S, Spiegl N, Dahinden CA, (2009). Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 113: 1526-1534.
41. Pinto LG, Cunha TM, Vieira SM, Lemos HP, Verri WA Jr, Cunha FQ, et al. (2010). IL-17 mediates articular hyperalgesia in antigen-induced arthritis in mice. Pain 148: 247-256.
42. Poole S, Cunha FQ, Selkirk S, Lorenzetti BB, Ferreira SH, (1995). Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10. Br J Pharmacol 115: 684-688.
43. Pushparaj PN, Tay HK, H'ng SC, Pitman N, Xu D, McKenzie A, et al. (2009). The cytokine interleukin-33 mediates anaphylactic shock. Proc Natl Acad Sci U S A 106: 9773-9778.
44. Savinko T, Matikainen S, Saarialho-Kere U, Lehto M, Wang G, Lehtimäki S, et al. (2012). IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors. J Invest Dermatol 132: 1392-1400.
45. Schmieder A, Multhoff G, Radons J, (2012). Interleukin-33 acts as a pro-inflammatory cytokine and modulates its receptor gene expression in highly metastatic human pancreatic carcinoma cells. Cytokine 60: 514-521.
46. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, et al. (2005). IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490.
47. Smithgall MD, Comeau MR, Yoon BR, Kaufman D, Armitage R, Smith DE, (2008). IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol 20: 1019-1030.
48. Valério DA, Cunha TM, Arakawa NS, Lemos HP, Da Costa FB, Parada CA, et al. (2007). Anti-inflammatory and analgesic effects of the sesquiterpene lactone budlein A in mice: inhibition of cytokine production-dependent mechanism. Eur J Pharmacol 562: 155-163.
49. Verri WA Jr, Molina RO, Schivo IR, Cunha TM, Parada CA, Poole S, et al. (2005). Nociceptive effect of subcutaneously injected interleukin-12 is mediated by endothelin (ET) acting on ETB receptors in rats. J Pharmacol Exp Ther 315: 609-615.
50. Verri WA Jr, Cunha TM, Parada CA, Wei XQ, Ferreira SH, Liew FY, et al. (2006). IL-15 mediates immune inflammatory hyperalgesia by triggering a sequential release of IFN-γ, endothelin, and prostaglandin. Proc Natl Acad Sci U S A 103: 9721-9725.
51. Verri WA Jr, Cunha TM, Parada CA, Poole S, Liew FY, Ferreira SH, et al. (2007). Antigen-induced inflammatory mechanical hyperalgesia in mice is mediated by IL-18. Brain Behav Immun 21: 535-543.
52. Verri WA Jr, Guerrero AT, Fukada SY, Valerio DA, Cunha TM, Xu D, et al. (2008). IL-33 mediates antigen-induced cutaneous and articular hyperalgesia in mice. Proc Natl Acad Sci U S A 105: 2723-2728.
53. Verri WA Jr, Cunha TM, Magro DA, Guerrero AT, Vieira SM, Carregaro V, et al. (2009). Targeting endothelin ETA and ETB receptors inhibits antigen-induced neutrophil migration and mechanical hyperalgesia in mice. Naunyn Schmiedebergs Arch Pharmacol 379: 271-279.
54. Verri WA Jr, Souto FO, Vieira SM, Almeida SC, Fukada SY, Xu D, et al. (2010). IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy. Ann Rheum Dis 69: 1697-1703.
55. Williams TJ, (1982). Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin. Br J Pharmacol 77: 505-509.
56. Williams TJ, Jose PJ, Wedmore CV, Peck MJ, Forrest MJ, (1983). Mechanisms underlying inflammatory oedema: the importance of synergism between prostaglandins, leukotrienes, and complement-derived peptides. Adv Prostaglandin Thromboxane Leukot Res 11: 33-37.
57. Xu D, Jiang HR, Kewin P, Li Y, Mu R, Fraser AR, et al. (2008). IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci U S A 105: 10913-10918.
58. Zarpelon AC, Pinto LG, Cunha TM, Vieira SM, Carregaro V, Souza GR, et al. (2012). Endothelin-1 induces neutrophil recruitment in adaptive inflammation via TNFα and CXCL1/CXCR2 in mice. Can J Physiol Pharmacol 90: 187-199.
59. Zhang L, Lu R, Zhao G, Pflugfelder SC, Li DQ, (2011). TLR-mediated induction of pro-allergic cytokine IL-33 in ocular mucosal epithelium. Int J Biochem Cell Biol 43: 1383-1391.